Evoke Pharma (EVOK) Tops Q2 EPS by 4c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform